Published in Prog Clin Biol Res on January 01, 1989
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 5.68
Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques. Neurobiol Dis (2014) 0.84
Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease. Curr Alzheimer Res (2016) 0.75
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07
Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med (1980) 9.38
Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun (1984) 8.14
Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92
Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci (1991) 5.71
X-ray diffraction studies on amyloid filaments. J Histochem Cytochem (1968) 4.54
Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science (1971) 4.27
Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N Engl J Med (1980) 3.95
Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci U S A (1985) 3.54
The isolation and amino acid composition of senile plaque core protein. Brain Res (1983) 3.26
Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science (1971) 3.14
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med (1997) 2.95
Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem (1974) 2.69
The occult aftermath of boxing. J Neurol Neurosurg Psychiatry (1990) 2.41
Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem (1988) 2.24
Amyloidosis: its nature and pathogenesis. Semin Hematol (1973) 2.21
The ultrastructure of human amyloid as revealed by the negative staining technique. J Ultrastruct Res (1966) 2.13
Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer's disease. Neurosci Lett (1986) 2.01
A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie (1966) 1.98
Amyloid, amyloidosis, and amyloidogenesis. Int Rev Exp Pathol (1976) 1.97
Amino acid sequence of an amyloid fibril protein of unknown origin. J Biol Chem (1972) 1.90
Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay. J Immunol (1976) 1.89
Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin. Proc Natl Acad Sci U S A (1975) 1.84
Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C. Stroke (1990) 1.67
The immunoglobulin origin of amyloid. Am J Med (1972) 1.64
Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. Lab Invest (1989) 1.56
Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol (1981) 1.51
Structural identity of Bence Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis. J Clin Invest (1973) 1.51
The amyloid deposits in Alzheimer's disease: their nature and pathogenesis. Appl Pathol (1984) 1.49
Ultrastructure of the human carotid body. A perspective on the mode of chemoreception. Circulation (1968) 1.48
CNS amyloid proteins in neurodegenerative diseases. Neurology (1988) 1.47
Human amyloid protein: chemical variability and homogeneity. J Histochem Cytochem (1971) 1.45
Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein. Acta Neuropathol (1991) 1.43
Gelatinase A not alpha-secretase? Nature (1994) 1.40
Immunochemical cross-reactions of human amyloid proteins with human immunoglobulin light polypeptide chains. J Immunol (1972) 1.39
A hog kidney aminopeptidase liberating N-terminal dipeptides. Partial purification and characteristics. Acta Chem Scand (1968) 1.38
Histology and ultrastructure of carotid body paragangliomas. Comparison with the normal gland. Cancer (1967) 1.36
Primary localized amyloidosis of the genitourinary tract: immunohistochemical study on eleven cases. Lab Invest (1981) 1.34
Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain (2002) 1.32
The relation of the properties of Congo red-stained amyloid fibrils to the -conformation. J Histochem Cytochem (1972) 1.32
Senile plaque amyloid, paired helical filaments, and cerebrovascular amyloid in Alzheimer's disease are all deposits of the same protein. Lancet (1985) 1.31
Murine amyloidosis: immunologic characterization of amyloid fibril protein. J Immunol (1971) 1.25
Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia). Med Hypotheses (1979) 1.24
Physical and chemical properties of amyloid fibers. II. Isolation of a unique protein constituting the major component from human splenic amyloid fibril concentrates. J Histochem Cytochem (1969) 1.21
An amyloid fibril protein of unknown origin: partial amino-acid sequence analysis. Biochem Biophys Res Commun (1972) 1.21
Primary amyloidosis. Ann Intern Med (1968) 1.20
Murine amyloid fibril protein: isolation, purification and characterization. J Histochem Cytochem (1971) 1.17
Amyloid A: amphipathic helixes and lipid binding. Biochemistry (1976) 1.15
Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains. Lab Invest (1989) 1.13
Infrared spectroscopy of human amyloid fibrils and immunoglobulin proteins. Biopolymers (1972) 1.13
The purification of amyloid fibril proteins. Prep Biochem (1972) 1.12
Purification of aminopeptidase A in human serum and degradation of angiotensin II by the purified enzyme. Biochim Biophys Acta (1970) 1.12
Immunoglobulin origin of localized nodular pulmonary amyloidosis. Res Exp Med (Berl) (1972) 1.11
Identification and classification of amyloid in formalin-fixed, paraffin-embedded tissue sections by the unlabeled immunoperoxidase method. Lab Invest (1980) 1.11
Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci (1994) 1.11
Pick's disease is associated with mutations in the tau gene. Ann Neurol (2000) 1.10
On causative theories in Alzheimer's disease. Hum Pathol (1985) 1.09
Characterization of aminopeptidase B: substrate specificity and affector studies. Arch Biochem Biophys (1966) 1.08
Amyloid. VI. A comparison of two morphologic components of human amyloid deposits. J Histochem Cytochem (1968) 1.08
An amyloid protein: the amino-terminal variable fragment of an immunoglobulin light chain. Biochem Biophys Res Commun (1970) 1.08
Purification of a mammalian peptidase selective for N-terminal arginine and lysine residues: aminopeptidase B. Arch Biochem Biophys (1966) 1.08
Immunochemical studies on the nature of the serum component (SAA) related to secondary amyloidosis. J Lab Clin Med (1977) 1.07
Amyloid. IX. Further kinetic studies on experimental murine amyloidosis. Int Arch Allergy Appl Immunol (1970) 1.06
Amyloid. 3. A method for rapid induction of amyloidosis in mice. Int Arch Allergy Appl Immunol (1968) 1.05
Protein aggregation, metals and oxidative stress in neurodegenerative diseases. Biochem Soc Trans (2005) 1.04
Quantitation of tissue-bound renal aminopeptidase by a microdensitometric technique. J Histochem Cytochem (1966) 1.04
The enzymatic hydrolysis of amino acid beta-naphthylamides. II. Partial purification and properties of a particle-bound cobalt-activated rat kidney aminopeptidase. J Histochem Cytochem (1966) 1.04
Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr Top Med Chem (2001) 1.03
Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer disease. Proc Natl Acad Sci U S A (1988) 1.03
Amyloid. IV. Is human amyloid immunogenic? Int Arch Allergy Appl Immunol (1968) 1.01
Amyloid. 8. On strain variability in experimental murine amyloidosis. Proc Soc Exp Biol Med (1969) 1.00
alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. Free Radic Biol Med (2001) 0.98
Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease. J Neurochem (1996) 0.97
Conformational flexibility of the serum amyloid precursor SAA. Br J Exp Pathol (1976) 0.97
Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide. Neurosci Lett (1993) 0.97
Cerebrovascular amyloid in scrapie-affected sheep reacts with antibodies to prion protein. Neurosci Lett (1988) 0.97
Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy. Hum Pathol (1990) 0.97
Chemical evidence for lambda-type amyloid fibril proteins. J Immunol (1972) 0.96
Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks beta/A4 amyloid immunoreactivity. Biochem Biophys Res Commun (1993) 0.93
Immunogold labeling of cerebrovascular and neuritic plaque amyloid fibrils in Alzheimer's disease with an anti-beta protein monoclonal antibody. Lab Invest (1987) 0.93
A demonstration of the advantages of immunostaining in the quantification of amyloid plaque deposits. Histochemistry (1989) 0.93
The bases of the staining of amyloid fibers: their physico-chemical nature and the mechanism of their dye-substrate interaction. Prog Histochem Cytochem (1981) 0.92
Serum aminopeptidases, "angiotensinase," and hypertension. I. Degradation of angiotensin II by human serum. Biochem Pharmacol (1965) 0.92
A peptidase (aminopeptidase B) from cat and guinea pig liver selective for N-terminal arginine and lysine residues. I. Purification and substrate specificity. Acta Chem Scand (1966) 0.92
Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. Neurobiol Dis (2011) 0.92
beta-Amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis. Lancet (1992) 0.91
The pathogenetic and therapeutic implications of the discovery of the immunoglobulin origin of amyloid fibrils. Hum Pathol (1972) 0.90
Alzheimer's disease. The commonest form of amyloidosis. Arch Pathol Lab Med (1983) 0.90
A pyrrolidonecarboxylate peptidase from the particulate fraction of Klebsiella cloacae. Purification of the stable enzyme and its use in releasing the NH2 terminus from pyrrolidonecarboxylyl peptides and proteins. J Biol Chem (1974) 0.90
Cathepsin C activity as related to some histochemical substrates. Histochemie (1965) 0.90
A method for electron microscopic localization of aryl-sulphatase. Ann Med Exp Biol Fenn (1965) 0.89
Amyloidosis. Its role in Alzheimer's disease and other diseases. Ann Pathol (1981) 0.89
Factor X deficiency and systemic amyloidosis. N Engl J Med (1977) 0.89
Purification and reconstitution of the periodic fibril and unit structure of human amyloid. Science (1966) 0.89
Isolated senile plaque cores in Alzheimer's disease and Down's syndrome show differences in morphology. J Neurol Neurosurg Psychiatry (1986) 0.88
Social interaction and wounding in the genesis of "spontaneous" murine amyloidosis. Am J Pathol (1972) 0.87